Differential efficacy of pembrolizumab according to...

  • Main
  • 2020 / 10
  • Differential efficacy of pembrolizumab according to...
Clinical Lung Cancer 2020 / 10

Differential efficacy of pembrolizumab according to metastatic sites in PD-L1 strong-positive (≥50%) NSCLC patients

Takeyasu, Yuki, Yoshida, Tatsuya, Ryota, Shibaki, Matsumoto, Yuji, Goto, Yasushi, Kanda, Shintaro, Horinouchi, Hidehito, Yamamoto, Noboru, Motoi, Noriko, Ohe, Yuichiro
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Clinical Lung Cancer
DOI:
10.1016/j.cllc.2020.10.002
Date:
October, 2020
File:
PDF, 1.29 MB
2020
Conversion to is in progress
Conversion to is failed